APA (7th ed.) Citation

G, I., SL, G., A, T., MRD, B., I, R., R, G., . . . NM, d. (2021). Feasibility of palliating recurrent gynecological tumors with MRGHIFU: Comparison of symptom, quality-of-life, and imaging response in intra and extra-pelvic disease. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 38(1), 623. https://doi.org/10.1080/02656736.2021.1904154

Chicago Style (17th ed.) Citation

G, Imseeh, Giles SL, Taylor A, Brown MRD, Rivens I, Gordon-Williams R, Ter Haar G, and deSouza NM. "Feasibility of Palliating Recurrent Gynecological Tumors with MRGHIFU: Comparison of Symptom, Quality-of-life, and Imaging Response in Intra and Extra-pelvic Disease." International Journal of Hyperthermia : The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 38, no. 1 (2021): 623. https://doi.org/10.1080/02656736.2021.1904154.

MLA (9th ed.) Citation

G, Imseeh, et al. "Feasibility of Palliating Recurrent Gynecological Tumors with MRGHIFU: Comparison of Symptom, Quality-of-life, and Imaging Response in Intra and Extra-pelvic Disease." International Journal of Hyperthermia : The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, vol. 38, no. 1, 2021, p. 623, https://doi.org/10.1080/02656736.2021.1904154.